NIH-funded research R01 grant

Understanding how a cellular process can help yeast live longer

Official title: Discovering how autophagy is sufficient to extend yeast replicative lifespan

Funded at Weill Medical Coll of Cornell Univ · NIH-11060925 · Data updated 2026-11-12

This study is looking at how a process that helps cells clean up damaged parts can help yeast live longer, and by figuring this out, researchers hope to find ways that might help people age healthier too.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWeill Medical Coll of Cornell Univ
NIH-funded
Lab location1 site (New York, United States)
Project startSeptember 1, 2023
Project endApril 30, 2028
Funding year2025
Award (this year)$524,263
NIH project number5R01AG079883-03
Project IDNIH-11060925 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research would be individuals interested in aging and longevity, particularly those with age-related conditions.

Less likely to help

Patients with acute or terminal conditions unrelated to aging may not receive benefit from this research.

What this research studies

This research investigates the role of autophagy, a cellular process that helps remove damaged components, in extending the lifespan of yeast cells. By studying how various interventions, such as medications and dietary changes, affect yeast's ability to replicate, the researchers aim to uncover the molecular mechanisms behind aging. The findings could provide insights into how similar processes might be applied to other organisms, including humans, to promote healthier aging. Patients may benefit from understanding these mechanisms as they could lead to new anti-aging therapies.

Why it matters

Potential benefit: If successful, this research could lead to breakthroughs in anti-aging therapies that improve healthspan and longevity in humans.

How similar studies have gone: Other research has shown promising results in extending lifespan through similar cellular mechanisms, indicating potential for success in this area.

Where this research is happening

  • Weill Medical Coll of Cornell Univ
    New York, United States
    Active

Researchers

  • Principal investigator: Tyler, Jessica K — Weill Medical Coll of Cornell Univ
  • Study coordinator: Tyler, Jessica K

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.